Skip to content
fx Medicine

fx Medicine Facebook ad: “Mastering women's metabolic health in the GLP-1 era |…”

fx Medicine Facebook ad: Mastering women's metabolic health in the GLP-1 era |…

Ran for 6 days, from July 28 to August 3, 2026, the last day Crush saw it.

Run by fx Medicine on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Want an ad like this for your product?

Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.

Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.

About this ad

Meta Ad Library ID
1360527896280701
Platforms
Facebook, Instagram, Audience Network and Messenger
Relaunches
0

How we count

Ad text

*Intended for healthcare professionals Three sessions. Three CPD hours. One rapidly evolving area of practice. Join clinical naturopath and women’s health expert Rhiannon Hardingham as she makes sense of the intersection of GLP-1 medications, female hormones and reproductive health. Hosted by Lisa Costa Bir Naturopath, this three-part program explores metabolism, PMOS, fertility and menopause, with case studies and clinical insights to support practitioner understanding of this complex topic. Delivering three hours of continuing professional development (ACA/ANTA/ATMS/CMA/NHAA), the series is available to watch on demand now at https://www.bioceuticals.com.au/education/programs/mastering-women-s-metabolic-health-in-the-glp-1-era #fxmedicine #fxmedicinebybioceuticals #integrativehealth #onlinelearning #glp1 #metabolichealth #weightmanagement #womenshealth #hormones #healthprofessional

bioceuticals.com.au

Mastering women's metabolic health in the GLP-1 era | BioCeuticals

Join us for an expert masterclass with Rhiannon Hardingham. A seminar hosted by Lisa Costa-Bir on GLP-1 receptor agonists and their impact on female metabolism throughout critical life stages.

Learn more: bioceuticals.com.au(opens in a new tab)

More from fx Medicine

See all fx Medicine ads

More ads from the top 1,000

See the top 1,000 ads